{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:10:55Z","timestamp":1790104255481,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/bjc.2015.471","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T09:36:41Z","timestamp":1455183401000},"page":"417-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer"],"prefix":"10.1038","volume":"114","author":[{"given":"Brittney S","family":"Harrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Beaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah K","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naven P","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J","family":"Crandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Flatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niara B","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"deFazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V","family":"Tinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal J","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jermaine I","family":"Coward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E","family":"Armes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis C","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,4]]},"reference":[{"issue":"11","key":"BFbjc2015471_CR1","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/onc.2014.88","volume":"34","author":"MN Adams","year":"2015","unstructured":"Adams MN, Harrington BS, He Y, Davies CM, Wallace SJ, Chetty NP, Crandon AJ, Oliveira NB, Shannon CM, Coward JI, Lumley JW, Perrin LC, Armes JE, Hooper JD (2015) EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface. Oncogene 34 (11): 1375\u20131383.","journal-title":"Oncogene"},{"issue":"1","key":"BFbjc2015471_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/path.2696","volume":"221","author":"AA Ahmed","year":"2010","unstructured":"Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, Bowtell D, Brenton JD (2010) Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 221 (1): 49\u201356.","journal-title":"J Pathol"},{"issue":"2","key":"BFbjc2015471_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","volume":"44","author":"M Al-Hussaini","year":"2004","unstructured":"Al-Hussaini M, Stockman A, Foster H, McCluggage WG (2004) WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology 44 (2): 109\u2013115.","journal-title":"Histopathology"},{"issue":"9","key":"BFbjc2015471_CR4","doi-asserted-by":"publisher","first-page":"e72162","DOI":"10.1371\/journal.pone.0072162","volume":"8","author":"MS Anglesio","year":"2013","unstructured":"Anglesio MS, Wiegand KC, Melnyk N, Chow C, Salamanca C, Prentice LM, Senz J, Yang W, Spillman MA, Cochrane DR, Shumansky K, Shah SP, Kalloger SE, Huntsman DG (2013) Type-specific cell line models for type-specific ovarian cancer research. PLoS One 8 (9): e72162.","journal-title":"PLoS One"},{"issue":"1","key":"BFbjc2015471_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/PAT.0b013e32835bd561","volume":"45","author":"JE Armes","year":"2013","unstructured":"Armes JE, Davies CM, Wallace S, Taheri T, Perrin LC, Autelitano DJ (2013) AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation. Pathology 45 (1): 49\u201354.","journal-title":"Pathology"},{"issue":"12","key":"BFbjc2015471_CR6","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00432-008-0412-4","volume":"134","author":"Y Awakura","year":"2008","unstructured":"Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T, Myoumoto A, Akiyama H, Ito N, Kamoto T, Manabe T, Nobumasa H, Tsujimoto G, Ogawa O (2008) Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma. J Cancer Res Clin Oncol 134 (12): 1363\u20131369.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"BFbjc2015471_CR7","doi-asserted-by":"publisher","first-page":"e24420","DOI":"10.1371\/journal.pone.0024420","volume":"6","author":"RB Bankert","year":"2011","unstructured":"Bankert RB, Balu-Iyer SV, Odunsi K, Shultz LD, Kelleher RJ Jr, Barnas JL, Simpson-Abelson M, Parsons R, Yokota SJ (2011) Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis. PLoS One 6 (9): e24420.","journal-title":"PLoS One"},{"issue":"9","key":"BFbjc2015471_CR8","doi-asserted-by":"publisher","first-page":"e103988","DOI":"10.1371\/journal.pone.0103988","volume":"9","author":"CM Beaufort","year":"2014","unstructured":"Beaufort CM, Helmijr JC, Piskorz AM, Hoogstraat M, Ruigrok-Ritstier K, Besselink N, Murtaza M, van IWF, Heine AA, Smid M, Koudijs MJ, Brenton JD, Berns EM, Helleman J (2014) Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes. PLoS One 9 (9): e103988.","journal-title":"PLoS One"},{"issue":"5","key":"BFbjc2015471_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/onc.2011.262","volume":"31","author":"CH Benes","year":"2012","unstructured":"Benes CH, Poulogiannis G, Cantley LC, Soltoff SP (2012) The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility. Oncogene 31 (5): 653\u2013663.","journal-title":"Oncogene"},{"issue":"4","key":"BFbjc2015471_CR10","first-page":"426","volume":"9","author":"K Berezowski","year":"1996","unstructured":"Berezowski K, Stastny JF, Kornstein MJ (1996) Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 9 (4): 426\u2013429.","journal-title":"Mod Pathol"},{"issue":"8","key":"BFbjc2015471_CR11","first-page":"3668","volume":"45","author":"RN Buick","year":"1985","unstructured":"Buick RN, Pullano R, Trent JM (1985) Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 45 (8): 3668\u20133676.","journal-title":"Cancer Res"},{"issue":"25","key":"BFbjc2015471_CR12","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1038\/onc.2014.264","volume":"34","author":"Q Cai","year":"2015","unstructured":"Cai Q, Yan L, Xu Y (2015) Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells. Oncogene 34 (25): 3315\u20133324.","journal-title":"Oncogene"},{"issue":"35","key":"BFbjc2015471_CR13","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1038\/onc.2011.555","volume":"31","author":"B Casar","year":"2012","unstructured":"Casar B, He Y, Iconomou M, Hooper JD, Quigley JP, Deryugina EI (2012) Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells. Oncogene 31 (35): 3924\u20133938.","journal-title":"Oncogene"},{"issue":"2","key":"BFbjc2015471_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/onc.2012.547","volume":"33","author":"B Casar","year":"2014","unstructured":"Casar B, Rimann I, Kato H, Shattil SJ, Quigley JP, Deryugina EI (2014) In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated beta1 integrin and induction of FAK\/PI3K\/Akt motility signaling. Oncogene 33 (2): 255\u2013268.","journal-title":"Oncogene"},{"issue":"4","key":"BFbjc2015471_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","volume":"10","author":"RL Coleman","year":"2013","unstructured":"Coleman RL, Monk BJ, Sood AK, Herzog TJ (2013) Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol 10 (4): 211\u2013224.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"BFbjc2015471_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1309\/AJCPGXK0FR4MHIHB","volume":"134","author":"MS Derycke","year":"2010","unstructured":"Derycke MS, Pambuccian SE, Gilks CB, Kalloger SE, Ghidouche A, Lopez M, Bliss RL, Geller MA, Argenta PA, Harrington KM, Skubitz AP (2010) Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker. Am J Clin Pathol 134 (5): 835\u2013845.","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"BFbjc2015471_CR17","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1158\/1541-7786.MCR-09-0100","volume":"7","author":"EI Deryugina","year":"2009","unstructured":"Deryugina EI, Conn EM, Wortmann A, Partridge JJ, Kupriyanova TA, Ardi VC, Hooper JD, Quigley JP (2009) Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination. Mol Cancer Res 7 (8): 1197\u20131211.","journal-title":"Mol Cancer Res"},{"key":"BFbjc2015471_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1757-2215-7-70","volume":"7","author":"M Desjardins","year":"2014","unstructured":"Desjardins M, Xie J, Gurler H, Muralidhar GG, Sacks JD, Burdette JE, Barbolina MV (2014) Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids. J Ovarian Res 7: 70.","journal-title":"J Ovarian Res"},{"key":"BFbjc2015471_CR19","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/ncomms3126","volume":"4","author":"S Domcke","year":"2013","unstructured":"Domcke S, Sinha R, Levine DA, Sander C, Schultz N (2013) Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun 4: 2126.","journal-title":"Nat Commun"},{"issue":"13","key":"BFbjc2015471_CR20","doi-asserted-by":"publisher","first-page":"9792","DOI":"10.1074\/jbc.M111.335448","volume":"287","author":"Y Dong","year":"2012","unstructured":"Dong Y, He Y, de Boer L, Stack MS, Lumley JW, Clements JA, Hooper JD (2012) The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration. J Biol Chem 287 (13): 9792\u20139803.","journal-title":"J Biol Chem"},{"issue":"1","key":"BFbjc2015471_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ygyno.2015.08.017","volume":"139","author":"KM Elias","year":"2015","unstructured":"Elias KM, Emori MM, Papp E, MacDuffie E, Konecny GE, Velculescu VE, Drapkin R (2015) Beyond genomics: Critical evaluation of cell line utility for ovarian cancer research. Gynecol Oncol 139 (1): 97\u2013103.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"BFbjc2015471_CR22","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1073\/pnas.1222435110","volume":"110","author":"BM Emerling","year":"2013","unstructured":"Emerling BM, Benes CH, Poulogiannis G, Bell EL, Courtney K, Liu H, Choo-Wing R, Bellinger G, Tsukazawa KS, Brown V, Signoretti S, Soltoff SP, Cantley LC (2013) Identification of CDCP1 as a hypoxia-inducible factor 2alpha (HIF-2alpha) target gene that is associated with survival in clear cell renal cell carcinoma patients. Proc Natl Acad Sci USA 110 (9): 3483\u20133488.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"BFbjc2015471_CR23","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1158\/1078-0432.CCR-14-1292","volume":"20","author":"C Emmanuel","year":"2014","unstructured":"Emmanuel C, Chiew YE, George J, Etemadmoghadam D, Anglesio MS, Sharma R, Russell P, Kennedy C, Fereday S, Hung J, Galletta L, Hogg R, Wain GV, Brand A, Balleine R, MacConaill L, Palescandolo E, Hunter SM, Campbell I, Dobrovic A, Wong SQ, Do H, Clarke CL, Harnett PR, Bowtell DD, deFazio A (2014) Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. Clin Cancer Res 20 (24): 6618\u20136630.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"BFbjc2015471_CR24","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (5): E359\u2013E386.","journal-title":"Int J Cancer"},{"key":"BFbjc2015471_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-4757-1647-4_5","volume-title":"Human Tumor Cells in Vitro J Fogh","author":"J Fogh","year":"1975","unstructured":"Fogh J, Trempe G (1975) New human tumor cell lines. In Human Tumor Cells in Vitro J Fogh, (ed.). Plenum Press: New York, pp 115\u2013159."},{"key":"BFbjc2015471_CR26","doi-asserted-by":"crossref","unstructured":"Forbes SA, Bhamra G, Bamford S, Dawson E, Kok C, Clements J, Menzies A, Teague JW, Futreal PA, Stratton MR (2008) The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet Chapter 10, Unit 10.11.","DOI":"10.1002\/0471142905.hg1011s57"},{"issue":"1","key":"BFbjc2015471_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1021\/mp900236t","volume":"7","author":"K Fukuchi","year":"2010","unstructured":"Fukuchi K, Steiniger SC, Deryugina E, Liu Y, Lowery CA, Gloeckner C, Zhou B, Kaufmann GF, Quigley JP, Janda KD (2010) Inhibition of tumor metastasis: functional immune modulation of the CUB domain containing protein 1. Mol Pharm 7 (1): 245\u2013253.","journal-title":"Mol Pharm"},{"issue":"3","key":"BFbjc2015471_CR28","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/j.gastro.2013.05.049","volume":"145","author":"W Gao","year":"2013","unstructured":"Gao W, Chen L, Ma Z, Du Z, Zhao Z, Hu Z, Li Q (2013) Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential. Gastroenterology 145 (3): 636\u201346 e5.","journal-title":"Gastroenterology"},{"issue":"3","key":"BFbjc2015471_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/PAS.0000000000000353","volume":"39","author":"CB Gilks","year":"2015","unstructured":"Gilks CB, Irving J, Kobel M, Lee C, Singh N, Wilkinson N, McCluggage WG (2015) Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas. Am J Surg Pathol 39 (3): 357\u2013364.","journal-title":"Am J Surg Pathol"},{"issue":"34","key":"BFbjc2015471_CR30","doi-asserted-by":"publisher","first-page":"26162","DOI":"10.1074\/jbc.M109.096453","volume":"285","author":"Y He","year":"2010","unstructured":"He Y, Wortmann A, Burke LJ, Reid JC, Adams MN, Abdul-Jabbar I, Quigley JP, Leduc R, Kirchhofer D, Hooper JD (2010) Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta. J Biol Chem 285 (34): 26162\u201326173.","journal-title":"J Biol Chem"},{"key":"BFbjc2015471_CR31","doi-asserted-by":"crossref","unstructured":"He Y, Wu AC, Harrington BS, Davies CM, Wallace SJ, Adams MN, Palmer JS, Roche DK, Hollier BG, Westbrook TF, Hamidi H, Konecny GE, Winterhoff B, Chetty NP, Crandon AJ, Oliveira NB, Shannon CM, Tinker AV, Gilks CB, Coward JI, Lumley JW, Perrin LC, Armes JE, Hooper JD (2015) Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance. Oncogene (accepted for publication).","DOI":"10.1038\/onc.2015.101"},{"issue":"12","key":"BFbjc2015471_CR32","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/sj.onc.1206220","volume":"22","author":"JD Hooper","year":"2003","unstructured":"Hooper JD, Zijlstra A, Aimes RT, Liang H, Claassen GF, Tarin D, Testa JE, Quigley JP (2003) Subtractive immunization using highly metastatic human tumor cells identifies SIMA135\/CDCP1, a 135\u2009kDa cell surface phosphorylated glycoprotein antigen. Oncogene 22 (12): 1783\u20131794.","journal-title":"Oncogene"},{"issue":"3","key":"BFbjc2015471_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1349-7006.2008.01066.x","volume":"100","author":"J Ikeda","year":"2009","unstructured":"Ikeda J, Oda T, Inoue M, Uekita T, Sakai R, Okumura M, Aozasa K, Morii E (2009) Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung. Cancer Sci 100 (3): 429\u2013433.","journal-title":"Cancer Sci"},{"issue":"10","key":"BFbjc2015471_CR34","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1073\/pnas.1117135109","volume":"109","author":"J Kim","year":"2012","unstructured":"Kim J, Coffey DM, Creighton CJ, Yu Z, Hawkins SM, Matzuk MM (2012) High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci USA 109 (10): 3921\u20133926.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"BFbjc2015471_CR35","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","volume":"5","author":"M Kobel","year":"2008","unstructured":"Kobel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, Santos J, Swenerton K, Gilks CB, Huntsman D (2008) Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 5 (12): e232.","journal-title":"PLoS Med"},{"issue":"2","key":"BFbjc2015471_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/path.2744","volume":"222","author":"M Kobel","year":"2010","unstructured":"Kobel M, Reuss A, Bois A, Kommoss S, Kommoss F, Gao D, Kalloger SE, Huntsman DG, Gilks CB (2010) The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas. J Pathol 222 (2): 191\u2013198.","journal-title":"J Pathol"},{"issue":"12","key":"BFbjc2015471_CR37","doi-asserted-by":"publisher","first-page":"e53050","DOI":"10.1371\/journal.pone.0053050","volume":"7","author":"G Kollmorgen","year":"2012","unstructured":"Kollmorgen G, Bossenmaier B, Niederfellner G, Haring HU, Lammers R (2012) Structural requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation. PLoS One 7 (12): e53050.","journal-title":"PLoS One"},{"issue":"6","key":"BFbjc2015471_CR38","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.molonc.2013.08.009","volume":"7","author":"G Kollmorgen","year":"2013","unstructured":"Kollmorgen G, Niederfellner G, Lifke A, Spohn GJ, Rieder N, Harring SV, Bauss F, Burtscher H, Lammers R, Bossenmaier B (2013) Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy. Mol Oncol 7 (6): 1142\u20131151.","journal-title":"Mol Oncol"},{"issue":"4","key":"BFbjc2015471_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/00313020410001721555","volume":"36","author":"B Kumar","year":"2004","unstructured":"Kumar B, De Silva M, Venter DJ, Armes JE (2004) Tissue microarrays: a practical guide. Pathology 36 (4): 295\u2013300.","journal-title":"Pathology"},{"issue":"3","key":"BFbjc2015471_CR40","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177 (3): 1053\u20131064.","journal-title":"Am J Pathol"},{"issue":"44","key":"BFbjc2015471_CR41","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1038\/onc.2015.19","volume":"34","author":"C Leroy","year":"2015","unstructured":"Leroy C, Shen Q, Strande V, Meyer R, McLaughlin ME, Lezan E, Bentires-Alj M, Voshol H, Bonenfant D, Alex Gaither L (2015) CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases. Oncogene 34 (44): 5593\u20135598.","journal-title":"Oncogene"},{"issue":"4","key":"BFbjc2015471_CR42","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1073\/pnas.1017228108","volume":"108","author":"H Liu","year":"2011","unstructured":"Liu H, Ong SE, Badu-Nkansah K, Schindler J, White FM, Hynes RO (2011) CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc Natl Acad Sci USA 108 (4): 1379\u20131384.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"BFbjc2015471_CR43","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","volume":"43","author":"WG McCluggage","year":"2011","unstructured":"McCluggage WG (2011) Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology 43 (5): 420\u2013432.","journal-title":"Pathology"},{"issue":"3","key":"BFbjc2015471_CR44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5858\/2008-132-402-AOITGP","volume":"132","author":"K Mittal","year":"2008","unstructured":"Mittal K, Soslow R, McCluggage WG (2008) Application of immunohistochemistry to gynecologic pathology. Arch Pathol Lab Med 132 (3): 402\u2013423.","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"BFbjc2015471_CR45","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1158\/0008-5472.CAN-10-0220","volume":"70","author":"Y Miyazawa","year":"2010","unstructured":"Miyazawa Y, Uekita T, Hiraoka N, Fujii S, Kosuge T, Kanai Y, Nojima Y, Sakai R (2010) CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res 70 (12): 5136\u20135146.","journal-title":"Cancer Res"},{"issue":"1","key":"BFbjc2015471_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/gyno.2001.6353","volume":"83","author":"A Obermair","year":"2001","unstructured":"Obermair A, Hagenauer S, Tamandl D, Clayton RD, Nicklin JL, Perrin LC, Ward BG, Crandon AJ (2001) Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 83 (1): 115\u2013120.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"BFbjc2015471_CR47","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","volume":"24","author":"R Perets","year":"2013","unstructured":"Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT, Chen JY, Ohman AW, Stepule CD, Kwak S, Karst AM, Hirsch MS, Setlur SR, Crum CP, Dinulescu DM, Drapkin R (2013) Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell 24 (6): 751\u2013765.","journal-title":"Cancer Cell"},{"issue":"6","key":"BFbjc2015471_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1290\/1071-2690(2000)036<0357:COFNEO>2.0.CO;2","volume":"36","author":"DM Provencher","year":"2000","unstructured":"Provencher DM, Lounis H, Champoux L, Tetrault M, Manderson EN, Wang JC, Eydoux P, Savoie R, Tonin PN, Mes-Masson AM (2000) Characterization of four novel epithelial ovarian cancer cell lines. In Vitro Cell Dev Biol Anim 36 (6): 357\u2013361.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"5","key":"BFbjc2015471_CR49","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1073\/pnas.1011777108","volume":"108","author":"OV Razorenova","year":"2011","unstructured":"Razorenova OV, Finger EC, Colavitti R, Chernikova SB, Boiko AD, Chan CK, Krieg A, Bedogni B, LaGory E, Weissman IL, Broome-Powell M, Giaccia AJ (2011) VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration. Proc Natl Acad Sci USA 108 (5): 1931\u20131936.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2015471_CR50","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.14694\/EdBook_AM.2014.34.e258","volume":"34","author":"Clare L. Scott","year":"2014","unstructured":"Scott CL, Mackay HJ, Haluska Jr P (2014) Patient-derived xenograft models in gynecologic malignancies. Am Soc Clin Oncol Educ Book e258\u2013e266.","journal-title":"American Society of Clinical Oncology Educational Book"},{"issue":"3","key":"BFbjc2015471_CR51","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.4353","volume":"233","author":"CA Sherman-Baust","year":"2014","unstructured":"Sherman-Baust CA, Kuhn E, Valle BL, Shih IeM, Kurman RJ, Wang TL, Amano T, Ko MS, Miyoshi I, Araki Y, Lehrmann E, Zhang Y, Becker KG, Morin PJ (2014) A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development. J Pathol 233 (3): 228\u2013237.","journal-title":"J Pathol"},{"issue":"1","key":"BFbjc2015471_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63 (1): 11\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"BFbjc2015471_CR53","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/his.12651","volume":"67","author":"N Singh","year":"2015","unstructured":"Singh N, Gilks CB, Wilkinson N, McCluggage WG (2015) Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum. Histopathology 67 (3): 331\u2013337.","journal-title":"Histopathology"},{"issue":"10","key":"BFbjc2015471_CR54","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1158\/0008-5472.CAN-07-1657","volume":"68","author":"AC Siva","year":"2008","unstructured":"Siva AC, Wild MA, Kirkland RE, Nolan MJ, Lin B, Maruyama T, Yantiri-Wernimont F, Frederickson S, Bowdish KS, Xin H (2008) Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model. Cancer Res 68 (10): 3759\u20133766.","journal-title":"Cancer Res"},{"issue":"6","key":"BFbjc2015471_CR55","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2353\/ajpath.2008.070981","volume":"172","author":"T Uekita","year":"2008","unstructured":"Uekita T, Tanaka M, Takigahira M, Miyazawa Y, Nakanishi Y, Kanai Y, Yanagihara K, Sakai R (2008) CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma. Am J Pathol 172 (6): 1729\u20131739.","journal-title":"Am J Pathol"},{"issue":"10","key":"BFbjc2015471_CR56","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan S, Coward JI, Bast RC Jr, Berchuck A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R, Etemadmoghadam D, Friedlander M, Gabra H, Kaye SB, Lord CJ, Lengyel E, Levine DA, McNeish IA, Menon U, Mills GB, Nephew KP, Oza AM, Sood AK, Stronach EA, Walczak H, Bowtell DD, Balkwill FR (2011) Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 11 (10): 719\u2013725.","journal-title":"Nat Rev Cancer"},{"issue":"49","key":"BFbjc2015471_CR57","doi-asserted-by":"publisher","first-page":"42303","DOI":"10.1074\/jbc.M111.227462","volume":"286","author":"A Wortmann","year":"2011","unstructured":"Wortmann A, He Y, Christensen ME, Linn M, Lumley JW, Pollock PM, Waterhouse NJ, Hooper JD (2011) Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734. J Biol Chem 286 (49): 42303\u201342315.","journal-title":"J Biol Chem"},{"issue":"7","key":"BFbjc2015471_CR58","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/iub.198","volume":"61","author":"A Wortmann","year":"2009","unstructured":"Wortmann A, He Y, Deryugina EI, Quigley JP, Hooper JD (2009) The cell surface glycoprotein CDCP1 in cancer\u2014insights, opportunities, and challenges. IUBMB Life 61 (7): 723\u2013730.","journal-title":"IUBMB Life"},{"issue":"9","key":"BFbjc2015471_CR59","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","volume":"24","author":"A Yemelyanova","year":"2011","unstructured":"Yemelyanova A, Vang R, Kshirsagar M, Lu D, Marks MA, Shih IeM, Kurman RJ (2011) Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol 24 (9): 1248\u20131253.","journal-title":"Mod Pathol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2015471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015471","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:31:33Z","timestamp":1684416693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2015471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFbjc2015471"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2015.471","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"10 November 2015","order":1,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2016","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JDH is an inventor on a patent describing CDCP1 as an anti-cancer target.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}